Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 1, 1997, Pages 226-232

  Hoke, J Frank ^a,c   Cunningham, Francesca ^b   James, Michael K ^a   Muir, Keith T ^a   Hoffman, William E ^b  

^a GLAXOSMITHKLINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 [4 METHOXYCARBONYL 4 (N PHENYLPROPIONAMIDO)PIPERIDINO]PROPIONIC ACID; ALFENTANIL; REMIFENTANIL;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; DOG; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENCY; ELECTROENCEPHALOGRAM; MALE; NONHUMAN; PRIORITY JOURNAL;

ALFENTANIL; ANALGESICS, OPIOID; ANIMALS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; MALE; PIPERIDINES;

EID: 0030911456     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. BERNAREGGI, A. AND ROWLAND, M.: Physiologic modeling of cyclosporin kinetics in rat and man. J. Pharmacokinet. Biopharm. 19: 21-50, 1991.
2. BOVILL, J. G., SEBEL, P. S., WAUQUIER, A., ROG, P. AND SCHUYT, H. C.: Influence of high-dose alfentanil anesthesia on the electroencephalogram: Correlation with plasma concentrations. Br. J. Anaesth. 55: 199S-209S, 1983.
3. BOXENBAUM, H. G., RIEGELMAN, S. AND ELASHOFF, R. M.: Statistical estimations in pharmacokinetics. J. Pharmacokinet. Biopharm. 2: 123-148, 1974.
4. EGAN, T. D., MINTO, C., LEMMENS, H. J. M., MUIR, K. T., HERMANN, D. J. AND SMAFER, S. L.: Remifentanil versus alfentanil: Comparative pharmacodynamics. Anesthesiology 81: A374, 1994a.
5. EGAN, T. D., MINTO, C., LEMMENS, H. J. M., MUIR, K. T., HERMANN, D. J. AND SHAFER, S. L.: Remifentanil versus alfentanil: Comparative pharmacokinetics. Anesthesiology 81: A373, 1994b.
6. FELDMAN, P. L., JAMES, M. K. BHACKEEN, M. F., BILOTTA, J. M., SCHUSTER, S. V., LAHEY, A. P., LUTZ, M. W., JOHNSON, M. R. AND LEIGHTON, H. J.: Design synthesis and pharmacological evaluation of ultrashort- to long-acting opioid analgetics. J. Med. Chem. 34: 2202-2208, 1991.
7. GIBALDI, M. AND PERRIER, D.: Pharmacokinetics. 2nd ed., Marcel Dekker, New York, 1982.
8. GLASS, P. S. A., HARDMAN, D., KAMIYAMA, Y., QUILL, T. J., MARTON, G., DONN, K. H., GROUSE, C. M. AND HERMANN, D.: Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: Remifentanil (GI87084). Anesth. Analg. 77: 1031-1040, 1993.
9. GROSSSE, C. M., DAVIS, I. M., ARRENDALE, R., JERSEY, J. AND AMIN, J.: Determination of GI87084 in human blood by liquid-liquid extraction and GC/ HRMS/SIM using deuterated internal standard. J. Pharm. Biomed. Anal. 12: 195-203, 1994.
10. HALL, R. I., SZLAM, F. AND HUG, C. C.: The enflurane sparing effect of alfentanil in dogs. Anesth. Analg. 66: 1287-1291, 1994.
11. HOFFMAN, W. E., CUNNNIGHAM, F., JAMES, M. K., BAUGHMAN, V. L. AND ALBRECHT, R. F.: Effects of remifentanil. a new short-acting opioid, on cerebral blood flow, brain electrical activity, and intracranial pressure in dogs anesthetized with isoflurane and nitrous oxide. Anesthesiology 79: 107-113, 1993.
12. HOLFORD, N. H. G. AND SHEINER, L. B.: Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models. Clin. Pharmacokinet. 6: 429-453, 1981.
13. HOLFORD, N. H. G. AND SHEINER, L. B.: Kinetics of pharmacologic response. Pharmacol. Ther. 16: 143-166, 1982.
14. HULL, C. J., VAN BEEM, H. B. H., MCLEOD, K., SIBBALS, A. AND WATSON, M. J.: A pharmacodynamic model for pancuronium. Br. J. Anaesth. 50: 1113-1123, 1978.
15. JAMES, M. K.: Remifentanil and anesthesia for the future. Exp. Opin. Invest. Drugs 3: 331-340, 1994.
16. JERSEY, J. A., GUYAN, S., ABBEY, L., GROSSE, C. M. AND DAVIS, I. M.: Determination of alfentanil in whole blood by GC/MS using liquid-liquid and solid-phase extraction. Pharm. Res. 10: S55, 1993.
17. LAM, F. C., HUNG, C. T. AND PERRIER, D. G.: Estimation of variance for harmonic mean half-lives. J. Pharm. Sci. 74: 229-231, 1985.
18. SALMENPERA, M., WILSON, D., SZLAM, F. AND HUG, C. C.: Anesthetic potency of the opioid GI87084B in dogs. Anesthesiology 77: A368, 1992.
19. SCHUSTER, S. V., BILOTTA, J. M., LUTZ, M. W. AND JAMES, M. K.: Analgesic activity of the ultra-short acting opioid G187084. FASEB J. 5: A860, 1991.
20. SCOTT, J. G., COOKE, J. E. AND STANSKI, D. R.: Electroencephalographic quantitation of opioid effect: Comparative pharmacodynamics of fentanyl and sufentanil. Anesthesiology 74: 34-42, 1991.
21. SCOTT, J. C., PONGANIS, K. V. AND STANSKI, D. R.: EEG quantitation of narcotic effect: The comparative pharmacodynamics of fentanyl and alfentanil. Aneathesiology 62: 234-241, 1985.
22. SHEINER, L. B., STANSKI, D. R., VOZEH, S., MILLER, R. D. AND HAM, J.: Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clin. Pharmacol. Ther. 25: 350-371, 1979.
23. WESTMORELAND, C. L., HOKE, J. F., SEBEL, P. S., HUG, C. C. AND MUIR, K. T. Pharmacokinetics of remifentanil (GI87084) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Aneathesiology 79: 875-876, 1993.
24. YAMAOKA, K., NAKAGAWA, T. AND UNO, T.: Application of Akaike's information criterion (AIC) in evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 6: 165-175, 1978.